在耐火性心痛中冠状动脉鼻腔减动剂:针对微血管缺血和症状缓解的有针对性的方法
Hadrian Hoang-Vu Tran1, Audrey Thu2, Anu Radha Twayana3
1From the Department of Internal Medicine, Hackensack University Medical Center, Palisades Medical Center, North Bergen, NJ.
Cardiology in review
|July 17, 2025
概括
冠状动脉缩剂 (CSR) 为耐火性心痛提供了一种新的基于设备的治疗方法,可改善大多数患者的症状. 需要进一步的研究来证实长期的疗效,并确定最佳的患者选择这种有前途的治疗.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗器械 医疗器械
背景情况:
- 耐火性心痛是晚期冠状动脉疾病的一个重大挑战.
- 尽管最佳的医疗治疗和重血管化的局限性,但患者往往仍然表现出症状.
研究的目的:
- 审查冠状动脉缩剂 (CSR) 与现有疗法的比较有效性.
- 探索CSR在微血管与宏血管缺血中的作用.
主要方法:
- 随机试验和现实世界注册表评估企业社会责任的审查.
- 专注于症状改善,安全结果和患者子组.
主要成果:
- 在大多数患者中,CSR显示出显著的症状改善和有利的安全性.
- 不响应率在15%到30%之间.
- 新出现的证据表明,在微血管功能障碍中具有有效性.
结论:
- CSR是耐火性心痛的有前途的治疗方法,特别是在复杂的病例中.
- 需要进一步的临床验证,长期疗效研究和患者选择标准.
- 目前正在进行的COSIRA-II和REMEDY-PILOT等试验将解决目前的不确定性.
相关概念视频
Coronary Artery Disease V: Interprofessional Care
37
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
37
Angina IV: Management
27
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
27
Acute Coronary Syndrome IV: Interprofessional Care
32
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
32
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
702
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
702
Angina II: Classification
42
Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
42
Acute Coronary Syndrome V: Nursing Management
40
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
40


